Posted on by ScienceFather
57 / 100
Powered by Rank Math SEO

Mr. Sinethemba Yakobi | Antimicrobial Resistance | Best Researcher Award

Mr. Sinethemba Yakobi, University of KwaZulu Natal, South Africa

Sinethemba Hopewell Yakobi, a South African geneticist and medical technologist šŸ§¬. With a PhD in Biochemistry and extensive experience in clinical research, Yakobi specializes in genetics and assay development, particularly in Medical Microbiology and Virology. He has a proven track record in laboratory management, research, and publication. His work focuses on antimicrobial resistance, particularly in Neisseria gonorrhoeae. With leadership roles in academic and clinical settings, Yakobi is known for his meticulous attention to detail and commitment to advancing medical knowledge. šŸ„šŸ’”

Publication Profile:

Orcid

Education:

Sinethemba Hopewell Yakobi embarked on his academic journey at Lady Grey Arts Academy, where he completed his Grade 12 education in 2008. Driven by a passion for science, he pursued a National Diploma in Biomedical Technology at Cape Peninsula University of Technology in 2011, specializing in Clinical Pathology. Building on this foundation, he obtained a Bachelor of Technology in Biomedical Technology in 2012, majoring in Molecular Biology and Laboratory Management. His pursuit of knowledge led him to complete a Master of Technology in Biomedical Technology at Cape Peninsula University of Technology in 2016, focusing on Molecular Biology and Microbiology. Currently, Yakobi is on the brink of receiving his PhD in Biochemistry from the University of KwaZulu Natal, with a thesis submission in February 2024 and graduation anticipated in April 2024. His academic journey reflects a relentless dedication to advancing scientific understanding and contributing to the field of medicine. šŸŽ“šŸ”¬

 

Research Experience:

Sinethemba Hopewell Yakobi’s research journey spans across esteemed institutions, showcasing his dedication to advancing medical science. At the University of KwaZulu Natal, Yakobi directed groundbreaking laboratory research on drug development for uncomplicated gonorrhoeae, aligning with FDA perspectives. šŸ§« His tenure at the Department of Biochemistry delved into isolating antimicrobial bioactive components from Pleurotus ostreatus mushrooms, exploring their potential against drug-resistant pathogens. šŸ„ Prior, at Cape Peninsula University of Technology, his investigation into antibiotic-resistant strains in wastewater underscored his commitment to understanding and combating microbial challenges. Yakobi’s research endeavors exemplify his pursuit of innovative solutions to pressing medical issues. šŸŒ±

 

Research Focus:

Sinethemba Yakobi’s research primarily focuses on combating antimicrobial resistance, particularly in Neisseria gonorrhoeae. šŸ¦  His studies delve into understanding the mechanisms of resistance and developing novel therapeutic strategies against drug-resistant strains. Yakobi’s contributions range from identifying emerging multidrug-resistant isolates to screening antimicrobial properties of natural compounds against various pathogens. Through molecular docking studies and structure-activity relationship analyses, he aims to elucidate potential targets for drug development, as seen in his investigation of compounds against glyceraldehyde-3-phosphate dehydrogenase in azithromycin-resistant Neisseria gonorrhoeae. šŸŽÆ His dedication to addressing pressing public health concerns underscores his commitment to advancing medical science.

Publication Top Notes:

Molecular Docking and Structureā€Activity Relationship Analysis of Target Compounds against Glyceraldehydeā€3ā€Phosphate Dehydrogenase in Azithromycinā€Resistant Neisseria gonorrhoeae

The Influence of OrganicĀ Phenolic Compounds on the Proliferation and Kinetic Growth of Pathogenic Multi-Drug Resistant Neisseria Gonorrhoeae Strains

Screening of Antimicrobial Properties and Bioactive Compounds of Pleurotus Ostreatus Extracts against Staphylococcus Aureus, Escherichia coli, and Neisseria Gonorrhoeae

Identification of Emerging Multidrug-Resistant Neisseria gonorrhoeae Isolates against Five Major Antimicrobial Agent Options

Antimicrobial Resistance of Neisseria gonorrhoeae in Sub-Saharan Populations

Monocyte-mediated inflammation and cardiovascular risk factors in type 2 diabetes mellitus: A systematic review and meta-analysis of pre-clinical and clinical studies

Sinethemba Yakobi | Antimicrobial Resistance | Best Researcher Award

You May Also Like